Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$16.95 - $27.04 $8,339 - $13,303
-492 Reduced 14.3%
2,949 $79,000
Q1 2024

May 10, 2024

BUY
$11.38 - $19.03 $20,700 - $34,615
1,819 Added 112.15%
3,441 $63,000
Q4 2023

Feb 12, 2024

SELL
$6.29 - $15.72 $46,464 - $116,123
-7,387 Reduced 82.0%
1,622 $19,000
Q3 2023

Nov 13, 2023

BUY
$14.99 - $32.65 $16,818 - $36,633
1,122 Added 14.23%
9,009 $135,000
Q2 2023

Aug 10, 2023

SELL
$29.76 - $46.14 $57,585 - $89,280
-1,935 Reduced 19.7%
7,887 $256,000
Q1 2023

May 12, 2023

BUY
$38.09 - $57.79 $20,492 - $31,091
538 Added 5.79%
9,822 $384,000
Q4 2022

Feb 10, 2023

SELL
$40.54 - $56.2 $46,418 - $64,349
-1,145 Reduced 10.98%
9,284 $490,000
Q3 2022

Nov 14, 2022

SELL
$36.98 - $49.2 $4,474 - $5,953
-121 Reduced 1.15%
10,429 $470,000
Q2 2022

Aug 10, 2022

BUY
$28.03 - $45.8 $12,361 - $20,197
441 Added 4.36%
10,550 $384,000
Q1 2022

May 04, 2022

BUY
$29.24 - $44.06 $63,597 - $95,830
2,175 Added 27.41%
10,109 $593,000
Q3 2021

Nov 05, 2021

BUY
$44.0 - $65.8 $63,580 - $95,081
1,445 Added 22.27%
7,934 $436,000
Q2 2021

Aug 02, 2021

SELL
$44.66 - $63.06 $33,807 - $47,736
-757 Reduced 10.45%
6,489 $310,000
Q1 2021

May 13, 2021

BUY
$46.31 - $62.7 $51,728 - $70,035
1,117 Added 18.22%
7,246 $368,000
Q4 2020

Feb 10, 2021

BUY
$55.51 - $69.94 $123,121 - $155,126
2,218 Added 56.71%
6,129 $386,000
Q3 2020

Nov 12, 2020

SELL
$42.19 - $69.61 $25,145 - $41,487
-596 Reduced 13.22%
3,911 $263,000
Q2 2020

Aug 14, 2020

BUY
$27.55 - $43.28 $78,930 - $123,997
2,865 Added 174.48%
4,507 $188,000
Q1 2020

May 18, 2020

BUY
$23.16 - $47.8 $38,028 - $78,487
1,642 New
1,642 $52,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.